Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed T-Cell Lymphoblastic Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04526795
What this trial is testing

Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Lymphoblastic Leukemia+8 more
M.D. Anderson Cancer Center 19
Early research (Phase 1)Study completedNCT00085150
What this trial is testing

LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI) 40
Very early researchUnknownNCT06393335
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
The Children's Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)Study completedNCT00293410
What this trial is testing

Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 70
Testing effectiveness (Phase 2)Study completedNCT00002718
What this trial is testing

T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center 31
Large-scale testing (Phase 3)Looking for participantsNCT07502118
What this trial is testing

NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)

Who this might be right for
Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL)Relapsed/Refractory Non-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma (DLBCL)+2 more
Health Institutes of Turkey 40
Testing effectiveness (Phase 2)Ended earlyNCT05464836
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

Who this might be right for
Leukemia, LymphoblasticLeukemia
M.D. Anderson Cancer Center 2
Not applicableEnded earlyNCT00899951
What this trial is testing

Studying Fentanyl in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Early research (Phase 1)Study completedNCT01164709
What this trial is testing

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more
Swiss Cancer Institute 18
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05289687
What this trial is testing

Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL

Who this might be right for
T-cell Acute Lymphoblastic Leukemia
Eastern Cooperative Oncology Group 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04703192
What this trial is testing

Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)

Who this might be right for
Relapsed/Refractory Peripheral T-Cell LymphomaAdult T Cell Leukemia/Lymphoma
Daiichi Sankyo 155
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00818961
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Northside Hospital, Inc. 36
Not applicableStudy completedNCT00866671
What this trial is testing

Observational Study of Nelarabine in Children and Young Adults

Who this might be right for
Leukaemia, Lymphoblastic, Acute
GlaxoSmithKline 28
Early research (Phase 1)UnknownNCT05554575
What this trial is testing

Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL

Who this might be right for
T Cell Lymphoblastic Lymphoma
Bioceltech Therapeutics, Ltd. 15
Early research (Phase 1)Active Not RecruitingNCT01860937
What this trial is testing

T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed B-Cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT06420076
What this trial is testing

Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells

Who this might be right for
T Cell LymphomaT Cell LeukemiaT-cell Acute Lymphoblastic Leukemia+3 more
Essen Biotech 60
Testing effectiveness (Phase 2)Ended earlyNCT00066417
What this trial is testing

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
National Heart, Lung, and Blood Institute (NHLBI) 51
Not applicableStudy completedNCT00499759
What this trial is testing

Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia

Who this might be right for
DepressionFatigueLeukemia+2 more
UNC Lineberger Comprehensive Cancer Center 10
Next Page